Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on June 3, 2025

Scaleup GC 2025: Europe’s Only Conference for In-House Legal Teams Returns to London for Fourth Year
Taking place on 11 June in Central London, Scaleup GC 2025, Europe’s only full-day conference designed for in-house legal and legal operations teams. LONDON, UNITED KINGDOM, June 3, 2025 /EINPresswire.com/ -- Juro, the leading contract automation …

Fennec Announces Results of Annual Meeting
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of …

Western New England Bancorp, Inc. Announces Completion of 2024 Repurchase Plan
WESTFIELD, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Western New England Bancorp, Inc. (the “Company” or “WNEB”) (NasdaqGS: WNEB), the holding company for Westfield Bank (the “Bank”), announced that on May 30, 2025, the Company completed all repurchases …

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …

Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa
ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30 Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …

Beyond Oil Issues Clarification Regarding Previous German-Language Media Activities
VANCOUVER, BC and KIBBUTZ YIFAT, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- As a result of a review by the British Columbia Securities Commission (the “BCSC”), Beyond Oil Ltd. (CSE: BOIL; OTCQB: BEOLF; Frankfurt: UH9) (“Beyond Oil” or the “Company”) today …

HeartCore Signs 15th Go IPO Contract
NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement (“ …

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024
Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, June 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …

Ingersoll Rand to Participate in Upcoming Investor Conference
DAVIDSON, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, and Matthew Fort, vice …

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

IGEL übernimmt Stratodesk: Mehr Reichweite und mehr Kompetenz im sicheren Endpoint Computing
FORT LAUDERDALE, Florida, June 03, 2025 (GLOBE NEWSWIRE) -- IGEL, die sichere Endpoint-OS-Plattform für SaaS, DaaS, VDI und sichere Enterprise-Browser, gibt heute die Übernahme von Stratodesk bekannt – einem renommierten Anbieter von Betriebssystem- und …

Carbon Revolution Announces Receipt of Non-Compliance Letter from Nasdaq
GEELONG, Australia, June 03, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that …

Effect of Altisource 1-for-8 Share Consolidation on Publicly Traded Warrants
LUXEMBOURG, June 03, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the effects of the recent …

Allotex Appoints Dirk Muehlhoff to its Board of Directors
Seasoned ophthalmic industry leader joins Allotex Board to strengthen strategic positioning and support global scale-up of its presbyopia correction platform. MILANO, ITALY, June 3, 2025 /EINPresswire.com/ -- Allotex group, a leader in natural tissue- …

Jushi Holdings Inc. Announces Voting Results of Annual Shareholders’ Meeting
BOCA RATON, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Corporation”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced the voting results of the annual general meeting (the “ …

PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for June 2025 of $0.08 per share, payable on July 1, 2025 to stockholders of record as of June 16, 2025. The …

Nasdaq Reports May 2025 Volumes
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for May 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About …

Epsilon Energy Ltd. Announces Quarterly Dividend
HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that its Board of Directors has declared a dividend of $0.0625 per share of common stock (annualized $0.25/sh) to the stock holders …